Geron Corp (GERN)
3.81
-0.09
(-2.31%)
USD |
NASDAQ |
May 17, 16:00
3.82
+0.01
(+0.26%)
After-Hours: 20:00
Geron Total Assets (Quarterly): 482.07M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 482.07M |
December 31, 2023 | 394.08M |
September 30, 2023 | 413.02M |
June 30, 2023 | 415.30M |
March 31, 2023 | 424.88M |
December 31, 2022 | 190.58M |
September 30, 2022 | 232.61M |
June 30, 2022 | 238.16M |
March 31, 2022 | 198.42M |
December 31, 2021 | 226.03M |
September 30, 2021 | 229.10M |
June 30, 2021 | 252.18M |
March 31, 2021 | 258.61M |
December 31, 2020 | 270.73M |
September 30, 2020 | 285.79M |
June 30, 2020 | 274.81M |
March 31, 2020 | 142.89M |
December 31, 2019 | 165.52M |
September 30, 2019 | 164.25M |
June 30, 2019 | 166.22M |
March 31, 2019 | 175.67M |
December 31, 2018 | 185.28M |
September 30, 2018 | 187.93M |
June 30, 2018 | 183.27M |
March 31, 2018 | 105.51M |
Date | Value |
---|---|
December 31, 2017 | 110.31M |
September 30, 2017 | 114.24M |
June 30, 2017 | 124.28M |
March 31, 2017 | 128.85M |
December 31, 2016 | 130.25M |
September 30, 2016 | 136.23M |
June 30, 2016 | 137.42M |
March 31, 2016 | 143.14M |
December 31, 2015 | 148.76M |
September 30, 2015 | 154.02M |
June 30, 2015 | 159.08M |
March 31, 2015 | 165.81M |
December 31, 2014 | 172.51M |
September 30, 2014 | 144.25M |
June 30, 2014 | 149.34M |
March 31, 2014 | 155.41M |
December 31, 2013 | 67.34M |
September 30, 2013 | 68.71M |
June 30, 2013 | 73.41M |
March 31, 2013 | 82.85M |
December 31, 2012 | 99.80M |
September 30, 2012 | 111.03M |
June 30, 2012 | 126.19M |
March 31, 2012 | 141.19M |
December 31, 2011 | 160.05M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
142.89M
Minimum
Mar 2020
482.07M
Maximum
Mar 2024
271.26M
Average
245.17M
Median
Total Assets (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | 1.082B |
SELLAS Life Sciences Group Inc | 24.43M |
Johnson & Johnson | 171.97B |
Pfizer Inc | 221.10B |
Immuneering Corp | 87.98M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 137.21M |
Shareholders Equity (Quarterly) | 344.87M |
Debt to Equity Ratio | 0.2399 |
Current Ratio | 3.666 |
Net Debt Paydown Yield | -0.32% |